htmc0435
Showing 1 - 1 of 1
Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)
Not yet recruiting
- Recurrent Extensive Stage Small Cell Lung Carcinoma
- HTMC0435
- Temozolomide
-
Hangzhou, China
- +2 more
Feb 5, 2023